Aminoquinazolines and their use as medicaments

US6617329B2 · kind B2 · utility

Assignee

• BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG · DE

Inventors

• Frank Himmelsbach · Mittelbiberach, DE
• Elke Langkopf · Biberach an der Riß, DE
• Birgit Jung · Laupheim, DE
• Stefan Blech · Warthausen, DE
• Flavio Solca · Wien, AT

Key dates

• Filing date: Aug 23, 2001
• Grant date: Sep 9, 2003
• Expiry date: Aug 23, 2021

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D413/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds of the formula having an inhibitory effect on signal transduction mediated by tyrosine kinases, their use in the treatment of diseases, especially tumoral diseases and diseases of the lungs and air-ways, and the preparation thereof.